Stocktwits on MSN
TRVI stock slips after company plans parallel trials in lung disease — Stifel dismisses timeline concerns
While one of the two late-stage trials will be initiated in the second quarter, the second will be kickstarted in the second half of this year, the company said. ・The company also said that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results